Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.64 | 2.01 |
NAV | ₹42.86 | ₹64.77 |
Fund Started | 09 Jul 2009 | 18 Jun 2012 |
Fund Size | ₹1907.50 Cr | ₹3112.72 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1% if redeemed within 1 month. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 18.82% | 11.50% |
3 Year | 3.92% | 16.17% |
5 Year | 0.37% | 14.13% |
1 Year
3 Year
5 Year
Equity | 0.00% | 97.91% |
Cash | 99.16% | 2.09% |
Equity
Cash
Top 10 Holdings | - |
|
Top 10 Holdings
Name | Assets |
---|---|
West Pharmaceutical Services Inc | 2.83% |
Huntington Ingalls Industries Inc. (US) | 2.81% |
Monolithic Power Systems Inc. | 2.59% |
Estee Lauder Stock | 2.56% |
Nike Inc. | 2.53% |
GE Healthcare Technologies Inc | 2.45% |
Pfizer INC | 2.42% |
Allegion PLC | 2.42% |
U.S. Bancorp | 2.41% |
Zimmer Biomet Holdings | 2.36% |
Name | Bharat Lahoti | Ritesh Lunawat |
Start Date | 18 Sep 2017 | 28 Dec 2020 |
Name
Start Date
Description | The Scheme is to provide long term capital appreciation by investing in JPMorgan Funds - JF Greater China Equity Fund, an equity fund which invests primarily in a diversified portfolio of companies incorporated or which have their registered office located in, or derive the predominant part of their economic activity from, a country in the Greater China region. | The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. |
Launch Date | 09 Jul 2009 | 18 Jun 2012 |
Description
Launch Date